chr14-90184776-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022054.4(KCNK13):āc.1000G>Cā(p.Glu334Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000301 in 1,613,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022054.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNK13 | NM_022054.4 | c.1000G>C | p.Glu334Gln | missense_variant | 2/2 | ENST00000282146.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNK13 | ENST00000282146.5 | c.1000G>C | p.Glu334Gln | missense_variant | 2/2 | 1 | NM_022054.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251090Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135826
GnomAD4 exome AF: 0.000315 AC: 460AN: 1461086Hom.: 0 Cov.: 32 AF XY: 0.000292 AC XY: 212AN XY: 726690
GnomAD4 genome AF: 0.000171 AC: 26AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.1000G>C (p.E334Q) alteration is located in exon 2 (coding exon 2) of the KCNK13 gene. This alteration results from a G to C substitution at nucleotide position 1000, causing the glutamic acid (E) at amino acid position 334 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at